Quick Answer
Decoy Therapeutics Inc. reported Research And Development Expense of $368.2 thousand for the year ending 2025.
- Decoy Therapeutics Inc. showed a decrease of -52.2% in Research And Development Expense from 2024 to 2025.
- This data is from Decoy Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), Decoy Therapeutics Inc.'s Research And Development Expense has grown by 1,126.3%.
- Historical annual values: Fiscal year 2025: $368.2 thousand | Fiscal year 2024: $770.0 thousand | Fiscal year 2023: $7.17 million | Fiscal year 2022: $15.84 million | Fiscal year 2021: $8.55 million | Fiscal year 2020: $6.91 million | Fiscal year 2019: $4.02 million | Fiscal year 2018: $1.29 million | Fiscal year 2017: $16.99 million | Fiscal year 2016: $20.38 million | Fiscal year 2015: $12.75 million | Fiscal year 2014: $30.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: